Skip to Main Content

Advertisement

American Association for Cancer Research Logo
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 9
1 September 2005
Molecular Cancer Therapeutics Cover Image for Volume 4, Issue 9
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice
Hong Cai; Mohammad Al-Fayez; Richard G. Tunstall; Sharon Platton; Peter Greaves; William P. Steward; Andreas J. Gescher
View articletitled, The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in <em>Apc<sup>Min</sup></em> mice
Open the PDF for in another window
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
Liya Yuan; Kihang Choi; Chaitan Khosla; Xiao Zheng; Ryuji Higashikubo; Michael R. Chicoine; Keith M. Rich
View articletitled, Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
Open the PDF for in another window
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Ralph J. Abi-Habib; Jeffrey O. Urieto; Shihui Liu; Stephen H. Leppla; Nicholas S. Duesbery; Arthur E. Frankel
View articletitled, BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Open the PDF for in another window
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824
Liwei Chen; Songshu Meng; Hai Wang; Purva Bali; Wenlong Bai; Benyi Li; Peter Atadja; Kapil N. Bhalla; Jie Wu
View articletitled, Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824
Open the PDF for in another window
Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
Christina Voelkel-Johnson; Yusuf A. Hannun; Ahmed El-Zawahry
View articletitled, Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C<sub>6</sub>-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
Open the PDF for in another window
Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
Marzia Pennati; Allyson J. Campbell; Maria Curto; Mara Binda; YuZhu Cheng; Lan-Zeng Wang; Nicola Curtin; Bernard T. Golding; Roger J. Griffin; Ian R. Hardcastle; Andrew Henderson; Nadia Zaffaroni; David R. Newell
View articletitled, Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
Open the PDF for in another window
Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma
Demetrius M. Kokkinakis; XiaoYan Liu; Russell D. Neuner
View articletitled, Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma
Supplementary data
Open the PDF for in another window
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts
Nathan T. Ihle; Gillian Paine-Murrieta; Margareta I. Berggren; Amanda Baker; Wendy R. Tate; Peter Wipf; Robert T. Abraham; D. Lynn Kirkpatrick; Garth Powis
View articletitled, The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts
Open the PDF for in another window
Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells
He-Kyung Kang; Eunmyong Lee; Hongryull Pyo; Soo-Jeong Lim
View articletitled, Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells
Open the PDF for in another window
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
C. Lynn Cheng; Stewart P. Johnson; Stephen T. Keir; Jennifer A. Quinn; Francis Ali-Osman; Csaba Szabo; Hongshan Li; Andrew L. Salzman; M. Eileen Dolan; Paul Modrich; Darell D. Bigner; Henry S. Friedman
View articletitled, Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
Open the PDF for in another window
An evaluation of the ability of pifithrin-α and -β to inhibit p53 function in two wild-type p53 human tumor cell lines
Mike I. Walton; Stuart C. Wilson; Ian R. Hardcastle; Amin R. Mirza; Paul Workman
View articletitled, An evaluation of the ability of pifithrin-α and -β to inhibit p53 function in two wild-type p53 human tumor cell lines
Open the PDF for in another window
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
Marie-Christine Brezak; Muriel Quaranta; Marie-Odile Contour-Galcera; Olivier Lavergne; Odile Mondesert; Pierrïck Auvray; Philip G. Kasprzyk; Gregoire P. Prevost; Bernard Ducommun
View articletitled, Inhibition of human tumor cell growth <em>in vivo</em> by an orally bioavailable inhibitor of CDC25 phosphatases
Open the PDF for in another window
Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells
Danhua Xiao; John T. Pinto; Gregg G. Gundersen; I. Bernard Weinstein
View articletitled, Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells
Open the PDF for in another window
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells
Jasti S. Rao; Christopher Gondi; Chandramu Chetty; Subramanyam Chittivelu; Pushpa A. Joseph; Sajani S. Lakka
View articletitled, Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells
Open the PDF for in another window
Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer
Haruhiko Fujino; Kazuya Kondo; Hisashi Ishikura; Hideo Maki; Hidetaka Kinoshita; Takanori Miyoshi; Yuji Takahashi; Naruhiko Sawada; Hiromitsu Takizawa; Taeko Nagao; Shoji Sakiyama; Yasumasa Monden
View articletitled, Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer
Open the PDF for in another window
Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging
Benjamin Solomon; David Binns; Peter Roselt; Leonard I. Weibe; Grant A. McArthur; Carleen Cullinane; Rodney J. Hicks
View articletitled, Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging
Open the PDF for in another window
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Marina V. Backer; Timur I. Gaynutdinov; Vimal Patel; Achintya K. Bandyopadhyaya; B.T.S. Thirumamagal; Werner Tjarks; Rolf F. Barth; Kevin Claffey; Joseph M. Backer
View articletitled, Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Open the PDF for in another window
Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
Joanna W.Y. Ho; Kwan Man; Chris K. Sun; Terence K. Lee; Ronnie T.P. Poon; Sheung Tat Fan
View articletitled, Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
Open the PDF for in another window
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis
Daniela Villa; Mariarosaria Miloso; Gabriella Nicolini; Roberta Rigolio; Antonello Villa; Guido Cavaletti; Giovanni Tredici
View articletitled, Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis
Open the PDF for in another window

Minireview

Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
Mi Sun Choe; Xin Zhang; Hyung Ju C. Shin; Dong M. Shin; Zhuo (Georgia) Chen
View articletitled, Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
Open the PDF for in another window

Correction

Article on antibody-endostatin fusion protein
View articletitled, Article on antibody-endostatin fusion protein
Open the PDF for in another window

Advertisement

Latest News
How Unruly DNA Loops Are Shaping Cancer—and Treatments
Global Platform Delivering Kids’ Cancer Drugs to Countries in Need
Cancer Grand Challenges Throws Down Gauntlet
View more recent articles
Breaking
HHS to Eliminate 10,000 Jobs
pNET/epNET Drug Gets Thumbs Up
Ovarian Cancer Trial Brought to a Halt
View more recent articles
Research Watch
HIF Drives Expression of Immunogenic Endogenous Retroviruses in Cancer
Neurons Form GABAergic Synapses that Promote Diffuse Midline Glioma
Synonymous Mutations in m6A-modified Sites Can Destabilize Tumor Suppressors
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept